RxDoctor Payments Data

Janae Jensen

Family · Meridian, IDNPI 1255030045

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 33.7% of the total. 2025 is the largest year on record at $765, 3.7 times the $206 reported in 2023.

$1,390in general payments, 2019–2025

Across 81 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$468
  • Novo Nordisk$241
  • AstraZeneca$178
  • Corcept Therapeutics$129
  • Lilly USA, LLC$50
  • Astellas Pharma US Inc$46
  • plus $278 from 14 others

What the payments were for

  • Food & beverage$1,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,390 in reported general payments places this provider in the 75th percentile of 809 family providers in Idaho.

See all family providers in Idaho →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Alprazolam13$29

Paid to pharmacies, not to this prescriber.

Other family in Meridian

See the full list for Idaho →

Where these figures come from

Is this you, or does something look wrong? →